After Aphria Inc. (APHA.TO) (APHA) and Tilray Inc.

New Post Public Reply Private Reply Replies (0) Message Board
Kgem
305
After Aphria Inc. (APHA.TO) (APHA) and Tilray Inc. (TLRY) announced a merger agreement in late 2020, there has been a substantial increase in the amount of merger and acquisition (M&A) activity in the Canadian cannabis sector.

Yesterday, Canopy Growth Corporation (WEED.TO) (CGC) announced a definitive agreement to acquire Canadian cannabis producer The Supreme Cannabis Company, Inc. (TSX: FIRE) (OTCQX: SPRWF) in a transaction that is valued at approx. $435 million on a fully diluted basis.

Going forward, we expect to see Canopy Growth acquire additional assets and highlighted this possibility in an article after it entered into a credit agreement for a US$750 million (USD) senior secured term loan in late March.

The combination of Aphria and Tilray seems to have lit a fire under Canopy Growth and additional Canadian cannabis producers. Canopy Growth’s acquisition comes a few days after Organigram Holdings Inc. (OGI.TO) (OGI) reported an agreement to acquire a cannabis edible brand. We expect Organigram to play a big role in future M&A transactions after it received a C$221 million strategic investment from a wholly-owned subsidiary of British American Tobacco (LSE: BATS) (NYSE:BTI).

Once the merger between Aphria and Tilray is complete, the combined company will be the world’s largest cannabis business and is expected to have a leading position on the international cannabis vertical. From the European Union (EU) to the United States (US), the combined company will have leverage to several strategic emerging international markets, and we are bullish on this aspect of the story.
Canopy Growth’s acquisition of Supreme Cannabis is expected to strengthen its leverage to Canada’s recreational market but will have less of an impact on the international cannabis opportunity.

Through an investment and partnership with Acreage Holdings Inc. (ACRG-AU.CN) (ACRHF), Canopy Growth has attractive leverage to the US market and will be able to capitalize on it when legislation permits.

Several Canadian and US cannabis companies have already acquired assets that are highly levered to the EU. We would not be surprised if Canopy Growth acquired assets that provide additional exposure to the EU and will monitor how the story advances from here.

Although Canada’s cannabis industry has matured, the global opportunity is still in the early innings and we expect the industry to record explosive growth over the next decade.



https://www.technical420.com/cannabis-article...mes-next/#

Scroll down for more posts ▼

Top 10 Most Recent News Articles

LG OLED evo W6: UAE Roadshow Starts with a Bang

Updated Category News Views 20

They've done it again, folks. LG Electronics is out there kicking up a storm with their all-new OLED evo W6 True Wireless Wallpaper TV, and they're bringing the action straight to the UAE's doorsteps. Imagine taking a stroll and stumbling upon this technological marvel at some fancy spot like The Lotus Lounge at Anantara The Palm Dubai Resort. This ain't just a TV, it's a...

Continue Reading
Weifang's Cultural Resurgence: A Global Epigraphy Fest

Updated Category News Views 13

A Historical Meltdown into Global Recognition Welcome to the ride where ancient stones talk and cultural borders vanish. We're diving into the beating heart of Weifang, a place you're probably hearing about now because the town's hosting a packed international media tour. And, for a change, this isn't just another tourist trap; it's a cultural adrenaline shot to the arm,...

Continue Reading
Innventure Faces Major Lawsuit Over Misleading Investors

Updated Category News Views 15

Missteps at Innventure: A Costly Lesson in Investor Trust The stock market is no stranger to drama, but Innventure's saga feels like a page ripped right out of a thriller novel. You’ve got accusations, alleged fabrications, and a swift drop in stock prices that’s left some investors shaking their heads. The company, nestled under the ticker NASDAQ:INV, finds itself...

Continue Reading
Masimo's smartSET™ Revolutionizes Patient Monitoring

Updated Category News Views 14

Breaking Ground in Patient Monitoring Let's dive into the gritty details behind Masimo's latest FDA-nod: the smartSET™ system. This gizmo ain't your ordinary pulse oximeter; it's a next-gen hand-holder for the medical world, poised to ride the AI wave straight into the clinic. They've cracked open a new way for clinicians to peek behind the curtain of patient vitals,...

Continue Reading
AEVEX Facing Class Action Deadline Amid Stock Turmoil

Updated Category News Views 14

Investors are no strangers to the rough and tumble of stock markets, but things get downright messy when trust is shattered. That's the sorry saga unfolding with AEVEX, where shareholders are feeling the heat after a sharp nosedive in stock value. The clock is ticking to join the class action, and any AEVEX investor worth their salt should pay attention. Unraveling...

Continue Reading
Voter Events by Valley Community Healthcare Aim to Empower

Updated Category News Views 14

Here's a game-changer for the community. Valley Community Healthcare (VCH) is stepping up, proving that healthcare doesn't just stick to check-ups and prescriptions. It's about the whole shebang—community empowerment included. This October, VCH is hosting two incredible voter events, collaborating with the Los Angeles County Registrar-Recorder's Mobile Voting Program....

Continue Reading
Hyliion Class Action Deadline Nears for Investors

Updated Category News Views 14

Potential Shockwaves for Hyliion Investors Investors are having a showdown with Hyliion (NYSE:HYLN) these days. With the looming October 27, 2026, deadline to jump into a securities class action, it seems Hyliion's latest escapade smells worse than a fish market on a hot day. We’ve got allegations here stronger than your uncle’s morning coffee. Understanding the Legal...

Continue Reading

Top 5 Most Recently Viewed Articles

FDA's NMN Ruling: Naturecan Seizes Opportunities for Growth

Updated Category News Views 158

FDA's NMN Ruling and Its Significance Naturecan, a prominent global wellness brand, is thrilled by the recent ruling from the U.S. Food and Drug Administration (FDA) regarding ?-Nicotinamide Mononucleotide (NMN). This ruling confirms that NMN is lawful for use in dietary supplements in the United States, paving the way for significant advancements within the global...

Continue Reading
Casepoint Secures Major SEC Contract for Innovative Data Solutions

Updated Category News Views 184

Casepoint Secures Important Contract Extension with the SEC Casepoint, a leading company in data discovery technology, has successfully extended its contract with the U.S. Securities and Exchange Commission (SEC). This five-year agreement highlights Casepoint's dedication to providing secure, cloud-based solutions designed for regulatory enforcement and compliance in a...

Continue Reading
Intel Corp's Future with Apple: Chip Manufacturing Wins

Updated Category News Views 359

Intel Corp's Significant Stock Surge Intel Corp (NASDAQ: INTC) saw its stock rise by 7%, thanks to a report signaling the company's exciting potential to produce chips for Apple Inc's upcoming Mac models. Industry analyst Ming-Chi Kuo from TF International Securities provided an optimistic outlook, suggesting Intel is gaining traction in its efforts to expand operations....

Continue Reading
Significant Phase II Breakthrough for Akeso's Ivonescimab in NSCLC

Updated Category News Views 195

Akeso's Promising Results with Ivonescimab for Lung Cancer Akeso (9926.HK) has recently shared exciting findings from the Phase II study of ivonescimab, a groundbreaking PD-1/VEGF bispecific antibody designed to treat resectable non-small cell lung cancer (NSCLC). This study was highlighted during a key oral session at the 25th World Conference on Lung Cancer (WCLC),...

Continue Reading
Insider Trades at Sherwin-Williams: A Closer Look at Rea's Moves

Updated Category News Views 204

Recent Insider Trading Activity at Sherwin-Williams Todd Rea, who holds the position of President at Sherwin-Williams (NYSE: SHW), has recently become the center of attention due to his stock option activities. The latest SEC filing reveals that he made a notable decision by exercising options for zero shares of the company’s stock. What This Means for Investors In the...

Continue Reading